Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

Press releases published on September 16, 2026

Sep. 16, 2026

Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division

Indeterminate GlobeNewswire

Sep. 16, 2026

Ennature Biopharma Advances Women’s Health Science With Fast-Acting Shatavari and Sustained-Release Ginger

Indeterminate GlobeNewswire

Sep. 16, 2026

Coave Therapeutics Strengthens Leadership Team to Advance Lead Gene Therapy Program into the Clinic

Indeterminate GlobeNewswire

Sep. 16, 2026

Shock Top and Spirit Halloween Brew Up a Scary Good Collaboration

Indeterminate GlobeNewswire

Sep. 16, 2026

Sironax Announces Option Exercise and Asset Purchase

Indeterminate GlobeNewswire

Sep. 16, 2026

NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference

Indeterminate GlobeNewswire

Sep. 16, 2026

Kailera Therapeutics to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 16, 2026

AAVantgarde to Showcase Clinical Progress in Usher 1B and Stargardt Disease at EURetina 2026

Indeterminate GlobeNewswire

Sep. 16, 2026

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 16, 2026

Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026

Indeterminate GlobeNewswire

Sep. 16, 2026

维泰瑞隆宣布其脑部递送平台收购选择权已获行使并完成交易

Indeterminate GlobeNewswire

Sep. 16, 2026

維泰瑞隆宣佈其腦部遞送平臺收購選擇權已獲行使並完成交易

Indeterminate GlobeNewswire

Sep. 16, 2026

Grey Matters Announces an Increase to its Equity and Convertible Debenture Private Placement to CAD $1.1 Million

Indeterminate GlobeNewswire

Sep. 16, 2026

Abalos Therapeutics Publishes Two Articles in Viruses Further Validating its AdaptInnate Approach to Treat Solid Tumors

Indeterminate GlobeNewswire

Sep. 16, 2026

Theolytics to Showcase its Innovative Oncolytic Immunotherapy Strategy – including THEO-260 in Advanced Ovarian Cancer – at Upcoming Investor and Scientific Events

Indeterminate GlobeNewswire

Sep. 16, 2026

EIB and Angelini Ventures’ Partnership Reaches €48.5 Million in Investments

Indeterminate GlobeNewswire

Sep. 16, 2026

UpFront Diagnostics Announces CE Mark Approval for LVOne — the World's First Rapid Blood Test to Diagnose Stroke

Indeterminate GlobeNewswire

Sep. 16, 2026

UpFront Diagnostics erhält CE-Zulassung für LVOne – weltweit erster Blut-Schnelltest zur Schlaganfalldiagnose

Indeterminate GlobeNewswire

Sep. 16, 2026

UpFront Diagnostics obtient le marquage CE pour LVOne, premier test sanguin rapide au monde destiné au diagnostic de l’AVC

Indeterminate GlobeNewswire

Sep. 16, 2026

EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Indeterminate GlobeNewswire